Deutsch English Français

Contact

EP1462455

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1462455

EP1462455 - Ser-Ser-Ser-Arg peptide and medicinal uses thereof [Right-click to bookmark this link]
Former [2004/40]	NOVEL PEPTIDES AND MEDICINAL USES THEREOF
	[2012/46]
Status	No opposition filed within time limit Status updated on 14.02.2014 Database last updated on 15.07.2024
Most recent event Tooltip	14.02.2014	No opposition filed within time limit	published on 19.03.2014 [2014/12]
Applicant(s)	For all designated states SANTEN PHARMACEUTICAL CO., LTD. 9-19, Shimoshinjo 3-chome Higashiyodogawa-ku, Osaka-shi Osaka 533-8651 / JP
	For all designated states Nishida, Teruo 8-4, Asutopia 6-chome Ube-shi Yamaguchi 755-0152 / JP
	[2013/15]
Former [2004/40]	For all designated states SANTEN PHARMACEUTICAL CO., LTD. 9-19, Shimoshinjo 3-chome Higashiyodogawa-ku, Osaka-shi, Osaka 533-8651 / JP
	For all designated states Nishida, Teruo 8-4, Asutopia 6-chome Ube-shi, Yamaguchi 755-0152 / JP
Inventor(s)	01 / NISHIDA, Teruo 8-4, Asutopia 6-chome Ube-shi, Yamaguchi 755-0152 / JP
	02 / INUI, Makoto 6-25-1001, Unoshimacho Ube-shi, Yamaguchi 755-0062 / JP
	03 / NAKAMURA, M. Santen Pharm. Co. Ltd. Kenkyusho 8916-16, Takayama-cho Ikoma-shi, Nara 630-0101 / JP
	[2012/46]
Former [2004/40]	01 / NISHIDA, Teruo 8-4, Asutopia 6-chome Ube-shi, Yamaguchi 755-0152 / JP
	02 / INUI, Makoto 6-25-1001, Unoshimacho Ube-shi, Yamaguchi 755-0062 / JP
	03 / NAKAMURA, M., c/o Santen Pharm. Co. Ltd. Kenkyusho 8916-16, Takayama-cho Ikoma-shi, Nara 630-0101 / JP
Representative(s)	Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE
	[N/P]
Former [2013/20]	Ter Meer Steinmeister & Partner Patentanwälte Mauerkircherstrasse 45 81679 München / DE
Former [2013/15]	TER MEER - STEINMEISTER & PARTNER GbR Patentanwälte Mauerkircherstrasse 45 81679 München / DE
Former [2004/40]	TER MEER STEINMEISTER & PARTNER GbR Patentanwälte, Mauerkircherstrasse 45 81679 München / DE
Application number, filing date	02786015.4	03.12.2002
	[2004/40]
	WO2002JP12632
Priority number, date	JP20010368103	03.12.2001 Original published format: JP 2001368103
	[2004/40]
Filing language	JA
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO03048192
	Date:	12.06.2003
	Language:	EN
	[2003/24]
	Type:	A1 Application with search report
	No.:	EP1462455
	Date:	29.09.2004
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 12.06.2003 takes the place of the publication of the European patent application.
	[2004/40]
	Type:	B1 Patent specification
	No.:	EP1462455
	Date:	10.04.2013
	Language:	EN
	[2013/15]
Search report(s)	International search report - published on:	JP	12.06.2003
	(Supplementary) European search report - dispatched on:	EP	01.12.2008
Classification	IPC:	C07K5/10, C07K7/06, A61K38/30, A61K9/06, A61K9/08, A61K9/70, A61P27/02, A61P17/02, C07K14/65, A61K9/00	[2012/46]
	CPC:	A61K38/30 (EP,US); A61K38/08 (KR); A61K38/07 (KR); A61K9/0048 (EP,KR,US); A61P17/00 (EP); A61P17/02 (EP); (+) A61P27/00 (EP); A61P27/02 (EP,KR); C07K14/65 (EP,US); C07K5/1013 (EP,US); C07K5/1016 (EP,US) (-)
	Former IPC [2004/40]	C07K5/10, C07K7/06, A61K38/30, A61K9/06, A61K9/08, A61K9/70, A61P27/02, A61P17/02, C07K14/65
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SI, SK, TR [2004/40]
Title	German:	Ser-Ser-Ser-Arg Peptid und medizinische Verwendungen davon	[2012/46]
	English:	Ser-Ser-Ser-Arg peptide and medicinal uses thereof	[2012/46]
	French:	Peptide Ser-Ser-Ser-Arg et son utilisation en tant que médicament	[2012/46]
	Former [2004/40]	NEUE PEPTIDE UND DEREN MEDIZINISCHE VERWENDUNGEN
	Former [2004/40]	NOVEL PEPTIDES AND MEDICINAL USES THEREOF
	Former [2004/40]	NOUVEAUX PEPTIDES ET LEURS UTILISATIONS EN TANT QUE MEDICAMENTS
Entry into regional phase	25.06.2004	Translation filed
	25.06.2004	National basic fee paid
	25.06.2004	Search fee paid
	25.06.2004	Designation fee(s) paid
	25.06.2004	Examination fee paid
Examination procedure	24.04.2003	Request for preliminary examination filed International Preliminary Examining Authority: JP
	25.06.2004	Examination requested [2004/40]
	25.02.2005	Amendment by applicant (claims and/or description)
	07.09.2009	Despatch of a communication from the examining division (Time limit: M04)
	18.01.2010	Reply to a communication from the examining division
	11.10.2010	Despatch of a communication from the examining division (Time limit: M04)
	02.02.2011	Reply to a communication from the examining division
	23.10.2012	Communication of intention to grant the patent
	27.02.2013	Fee for grant paid
	27.02.2013	Fee for publishing/printing paid
Divisional application(s)	EP10000425.8 / EP2172474
	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.09.2009
Opposition(s)	13.01.2014	No opposition filed within time limit [2014/12]
Fees paid	Renewal fee
	25.06.2004	Renewal fee patent year 03
	23.12.2005	Renewal fee patent year 04
	14.12.2006	Renewal fee patent year 05
	13.12.2007	Renewal fee patent year 06
	18.12.2008	Renewal fee patent year 07
	21.12.2009	Renewal fee patent year 08
	23.12.2010	Renewal fee patent year 09
	22.12.2011	Renewal fee patent year 10
	21.12.2012	Renewal fee patent year 11
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]WO9308826 (CEPHALON INC [US]) [X] 1 * sequences 63, 65, 66 *;
		[X]WO9323067 (UNIV JEFFERSON [US], et al) [X] 1,2 * claim 11 *;
		[X]EP0914827 (SANTEN PHARMACEUTICAL CO LTD [JP], et al) [X] 1-5,9-11 * paragraphs [0046] - [0048]; claims 1-6; table 3 *;
		[X]US6310040 (BOZYCZKO-COYNE DONNA [US], et al) [X] 1 * sequences 3,4,7,10-12 *;
		[E]EP1308165 (SANTEN PHARMACEUTICAL CO LTD [JP], et al) [E] 6-8,12-14* examples 1-3; claims 1,4,5,9,10 *;
		[X] - MASATSUGU NAKAMURA, TAI-ICHIRO CHIKAMA, TERUO NISHIDA, "Synergistic effect with Phe-Gly-Leu-Met-NH2 of the C-terminal of substance P and insulin-like growth factor-1 on epithelial wound healing of rabbit cornea", BRITISH JOURNAL OF PHARMACOLOGY, (199905), vol. 127, no. 2, pages 489 - 497, XP002504947 [X] 1-5,9-11 * figures 2,3,8 * DOI: http://dx.doi.org/10.1038/sj.bjp.0702550
		[X] - TAI-ICHIRO CHIKAMA ET AL., "Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I", LANCET THE, LANCET LIMITED. LONDON, GB, (19980613), vol. 351, no. 9118, ISSN 0140-6736, pages 1783 - 1788, XP004265387 [X] 1-3,5,9,11 * paragraphs [0001] - [0003] * DOI: http://dx.doi.org/10.1016/S0140-6736(98)24024-4
		[X] - MALORNI A ET AL, "Effect of matrix modification by strong mineral acids on the positive fast atom bombardment mass spectra of peptides", BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY, WILEY, LONDON, (19860901), vol. 13, no. 9, ISSN 0887-6134, pages 477 - 482, XP008088584 [X] 1 * figure 5 * DOI: http://dx.doi.org/10.1002/bms.1200130905
	International search	[X]WO9308826 (CEPHALON INC [US]);
		[X]WO9323067 (UNIV JEFFERSON [US], et al);
		[Y]WO9749419 (SANTEN PHARMACEUTICAL CO LTD [JP], et al)

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p